FGF23 protein expression in coronary arteries is associated with impaired kidney function
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGF23 protein expression in coronary arteries is associated with impaired kidney function
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 29, Issue 8, Pages 1525-1532
Publisher
Oxford University Press (OUP)
Online
2014-01-24
DOI
10.1093/ndt/gft523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dietary phosphate: the challenges of exploring its role in FGF23 regulation
- (2013) Marta Christov et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
- (2012) Kenneth Lim et al. CIRCULATION
- Fibroblast Growth Factor 23 and Inflammation in CKD
- (2012) J. Munoz Mendoza et al. Clinical Journal of the American Society of Nephrology
- Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease
- (2012) Mandy Wan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
- (2011) Yumie Rhee et al. BONE
- Early Skeletal and Biochemical Alterations in Pediatric Chronic Kidney Disease
- (2011) K. Wesseling-Perry et al. Clinical Journal of the American Society of Nephrology
- Expression of FGF23/KLOTHO system in human vascular tissue
- (2011) Javier Donate-Correa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
- (2011) M. Wolf et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma
- (2010) Mathias Voigt et al. HISTOPATHOLOGY
- Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
- (2010) M. C. Hu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Phosphorus and coronary calcification in predialysis patients
- (2010) Domenico Russo et al. KIDNEY INTERNATIONAL
- Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
- (2009) Renata C. Pereira et al. BONE
- Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro
- (2008) Hua Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal Dialysis
- (2008) Katherine Wesseling-Perry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started